HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 115 filers reported holding HARROW HEALTH INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,151,497 | -28.8% | 80,132 | -5.7% | 0.00% | – |
| Q2 2023 | $1,617,410 | +66.1% | 84,948 | +84.5% | 0.00% | – |
| Q1 2023 | $973,995 | -35.9% | 46,030 | -55.3% | 0.00% | – |
| Q4 2022 | $1,518,893 | +0.7% | 102,906 | -17.7% | 0.00% | -100.0% |
| Q3 2022 | $1,509,000 | +65.8% | 124,962 | 0.0% | 0.00% | – |
| Q2 2022 | $910,000 | +6.7% | 124,962 | 0.0% | 0.00% | – |
| Q1 2022 | $853,000 | -21.0% | 124,962 | 0.0% | 0.00% | – |
| Q4 2021 | $1,080,000 | -4.9% | 124,962 | 0.0% | 0.00% | – |
| Q3 2021 | $1,136,000 | -2.2% | 124,962 | 0.0% | 0.00% | – |
| Q2 2021 | $1,161,000 | +208.8% | 124,962 | +124.5% | 0.00% | – |
| Q1 2021 | $376,000 | -1.6% | 55,666 | 0.0% | 0.00% | – |
| Q4 2020 | $382,000 | +30.8% | 55,666 | +6.9% | 0.00% | – |
| Q3 2020 | $292,000 | +1.7% | 52,060 | -5.4% | 0.00% | – |
| Q2 2020 | $287,000 | – | 55,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |